Walleye Trading’s Structure Therapeutics GPCR Stock Holding History

Walleye Trading’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,485	Closed	-$330K	–	4296
2024 Q4	$366K	Buy	13,485 +4,909	+57%	+$174K	﹤0.01%	2840
2024 Q3	$376K	Buy	+8,576	New	+$332K	﹤0.01%	2692
2024 Q1	–	Sell	-13,879	Closed	-$585K	–	4992
2023 Q4	$566K	Buy	+13,879	New	+$795K	﹤0.01%	2974

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Walleye Trading's GPCR Position: Q1 2025 in Review

Walleye Trading sold out of Structure Therapeutics (GPCR) in Q1 2025, closing a stake of 13,485 shares — an estimated $330K sold.

Walleye Trading first reported a position in GPCR in Q4 2023 and held it in 3 quarters. The position peaked at $566K in Q4 2023. 150 funds tracked by Wall St. Rank hold GPCR as of Q1 2025.

Walleye Trading reported no remaining Structure Therapeutics position as of Q1 2025 after selling out during the quarter.
Walleye Trading sold 13,485 Structure Therapeutics shares in Q1 2025, an estimated $330K.
Walleye Trading first reported a position in Structure Therapeutics in Q4 2023 and held it in 3 quarters.
Walleye Trading's Structure Therapeutics position peaked at $566K in Q4 2023.
150 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.